Polyp Detection Rate After Single Oral Dose of Methylene Blue MMX Modified Release Tablets Administered to Subjects Undergoing Outpatients Colonoscopy

NCT01520337 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 170

Last updated 2014-02-11

No results posted yet for this study

Summary

Polyp detection rate in colonoscopy following oral administration of MMX methylene blue tablets

Conditions

  • Polyp and Adenoma Detection During Colonoscopy

Interventions

DEVICE

oral tablet dye for detection of polyps during colonoscopy

oral tablet dye for improved detection of

Sponsors & Collaborators

  • Cosmo Technologies Ltd

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-01-31
Primary Completion
2013-03-31
Completion
2013-10-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01520337 on ClinicalTrials.gov